Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Sigma Lithium
SGML
$1.28B
| $1.45M | ﹤0.01% |
117,125
+9,049
| +8% | +$98.8K |
|
3227
LifeVantage
LFVN
$85.3M
| $1.44M | ﹤0.01% |
119,066
-3,773
| -3% | -$31.2K |
|
3228
Richmond Mutual Bancorp
RMBI
$254M
| $1.43M | ﹤0.01% |
111,089
+2,829
| +3% | +$34.9K |
|
3229
NewAmsterdam Pharma
NAMS
$3.34B
| $1.43M | ﹤0.01% |
86,322
+1,399
| +2% | +$24.2K |
|
3230
Biodesix
BDSX
$248M
| $1.43M | ﹤0.01% |
40,229
+13,536
| +51% | +$466K |
|
3231
FinWise Bancorp
FINW
$195M
| $1.43M | ﹤0.01% |
91,608
+16,309
| +22% | +$206K |
|
3232
Douglas Elliman
DOUG
$162M
| $1.43M | ﹤0.01% |
780,215
+3,766
| +0.5% | +$6.46K |
|
|
OPI
3233
DELISTED
Office Properties Income Trust
OPI
| $1.43M | ﹤0.01% |
654,645
-14,410
| -2% | -$32.7K |
|
3234
Alto Ingredients
ALTO
$340M
| $1.43M | ﹤0.01% |
885,516
-410
| -0% | -$617 |
|
3235
Epsilon Energy
EPSN
$173M
| $1.43M | ﹤0.01% |
243,147
+24,437
| +11% | +$131K |
|
|
ATYR
3236
aTyr Pharma
ATYR
$50.1M
| $1.42M | ﹤0.01% |
809,101
+146,417
| +22% | +$266K |
|
|
SCWX
3237
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.42M | ﹤0.01% |
160,430
+19,766
| +14% | +$149K |
|
|
GCTS
3238
GCT Semiconductor Holding
GCTS
$235M
| $1.42M | ﹤0.01% |
423,584
+8,458
| +2% | +$31.9K |
|
3239
Acme United Corp
ACU
$215M
| $1.42M | ﹤0.01% |
34,035
+190
| +0.6% | +$7.68K |
|
3240
Barnes & Noble Education
BNED
$443M
| $1.42M | ﹤0.01% |
152,839
+77,932
| +104% | +$804K |
|
3241
American Well
AMWL
$230M
| $1.39M | ﹤0.01% |
147,003
+5,097
| +4% | +$43.2K |
|
3242
Lantronix
LTRX
$266M
| $1.39M | ﹤0.01% |
338,202
+10,413
| +3% | +$39.3K |
|
3243
IAMGOLD
IAG
$10.5B
| $1.39M | ﹤0.01% |
264,288
+6,874
| +3% | +$31.7K |
|
|
FSFG
3244
DELISTED
First Savings Financial Group
FSFG
| $1.39M | ﹤0.01% |
58,253
+690
| +1% | +$15.1K |
|
3245
Hurco Companies Inc
HURC
$143M
| $1.38M | ﹤0.01% |
65,443
-509
| -0.8% | -$8.74K |
|
3246
NLI Holdings
NL
$317M
| $1.38M | ﹤0.01% |
185,598
+3,014
| +2% | +$19.4K |
|
|
RAPT
3247
DELISTED
RAPT Therapeutics
RAPT
| $1.37M | ﹤0.01% |
85,397
-192
| -0.2% | -$3.88K |
|
|
ZOM
3248
DELISTED
Zomedica Corp.
ZOM
| $1.36M | ﹤0.01% |
9,929,716
+321,395
| +3% | +$45.1K |
|
3249
CB Financial Services
CBFV
$193M
| $1.35M | ﹤0.01% |
48,357
+4,295
| +10% | +$109K |
|
3250
BlackSky Technology
BKSY
$1.19B
| $1.35M | ﹤0.01% |
284,017
+10,151
| +4% | +$80.3K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.